Published in Emerg Infect Dis on June 01, 2013
Influenza in long-term Dutch travelers in the tropics: symptoms and infections. BMC Infect Dis (2016) 0.75
Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico. PLoS One (2017) 0.75
Travellers and influenza: risks and prevention. J Travel Med (2017) 0.75
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Transmission of infectious diseases during commercial air travel. Lancet (2005) 3.97
Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis (2006) 3.69
Comparison of influenza serological techniques by international collaborative study. Vaccine (1994) 2.55
Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol (2011) 1.57
Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg (Lond) (1981) 1.51
Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis (2010) 1.47
Health problems in a large cohort of Americans traveling to developing countries. J Travel Med (2001) 1.32
Frequent travelers and rate of spread of epidemics. Emerg Infect Dis (2007) 1.29
Illness in returned travelers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units. J Travel Med (2006) 1.29
Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis (2009) 1.19
Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis (2005) 1.16
Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am (2005) 1.09
Impact of Travel-Related Health Impairments. J Travel Med (1997) 1.06
Outbreaks of pandemic (H1N1) 2009 and seasonal influenza A (H3N2) on cruise ship. Emerg Infect Dis (2010) 1.04
Influenza virus serology--a comparative study. J Virol Methods (1999) 0.97
Influenza: changing approaches to prevention and treatment in travelers. J Travel Med (2005) 0.94
Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis (2003) 0.93
Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis (2009) 0.92
Health risks among travelers--need for regular updates. J Travel Med (2008) 0.88
[The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season]. Ned Tijdschr Geneeskd (2007) 0.87
Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med (2005) 0.85
Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas. J Med Virol (2008) 0.83
Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season. Wkly Epidemiol Rec (2006) 0.83
Surveillance of influenza viruses isolated from travellers at Nagoya International Airport. Epidemiol Infect (2000) 0.83
Transmission of pandemic influenza A (H1N1) virus in a train in China. J Epidemiol (2011) 0.83
Outbreak news. Cholera, Iraq--update. Wkly Epidemiol Rec (2007) 0.81
Influenza in travellers. Curr Opin Infect Dis (2010) 0.81
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
H5N1 Virus Attachment to Lower Respiratory Tract. Science (2006) 6.34
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 4.86
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med (2008) 3.97
Host species barriers to influenza virus infections. Science (2006) 3.94
Virology: SARS virus infection of cats and ferrets. Nature (2003) 3.86
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (2013) 3.38
Design and use of conditional MHC class I ligands. Nat Med (2006) 3.01
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis (2010) 2.81
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis (2007) 2.58
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res (2004) 2.43
Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands. Eur J Public Health (2009) 2.32
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med (2004) 2.31
High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk behaviour. AIDS (2012) 2.29
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol (2010) 2.23
Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis (2009) 2.22
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature (2013) 2.17
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med (2009) 2.12
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci U S A (2003) 2.03
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2009) 1.99
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol (2004) 1.87
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol (2008) 1.85
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med (2003) 1.81
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol (2010) 1.81
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol (2005) 1.64
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A (2010) 1.63
Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004. Sex Transm Dis (2007) 1.61
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol (2010) 1.55
Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev Vaccines (2010) 1.51
Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses. Curr Opin Infect Dis (2005) 1.46
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One (2009) 1.44
Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am J Pathol (2011) 1.44
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol (2012) 1.40
Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes. J Control Release (2012) 1.39
Predictors for the uptake of recommended vaccinations in Mecca travelers who visited the Public Health Service Amsterdam for mandatory meningitis vaccination. J Travel Med (2011) 1.39
Risk of hepatitis B for travelers: is vaccination for all travelers really necessary? J Travel Med (2009) 1.38
Rapid sequencing of the non-coding regions of influenza A virus. J Virol Methods (2006) 1.35
Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment. Emerg Infect Dis (2011) 1.31
Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. J Gen Virol (2011) 1.29
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol (2008) 1.23
Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol (2013) 1.22
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J Infect Dis (2007) 1.18
Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children. J Virol (2011) 1.16
Declining incidence of imported malaria in the Netherlands, 2000-2007. Malar J (2010) 1.15
Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination. PLoS One (2011) 1.15
A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol (2007) 1.14
Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011. J Virol (2013) 1.13
Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J Biomed Biotechnol (2011) 1.13
Highly pathogenic avian influenza virus H7N7 isolated from a fatal human case causes respiratory disease in cats but does not spread systemically. Am J Pathol (2010) 1.12
Lack of CD200 enhances pathological T cell responses during influenza infection. J Immunol (2009) 1.11
Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol (2010) 1.11
Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine (2010) 1.10
Recurring influenza B virus infections in seals. Emerg Infect Dis (2013) 1.09
The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. J Virol (2006) 1.09
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine (2007) 1.09
Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. J Gen Virol (2010) 1.09
Preferential HLA usage in the influenza virus-specific CTL response. J Immunol (2004) 1.08
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control. Hum Vaccin (2009) 1.07
Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination. PLoS One (2013) 1.07
Evasion of influenza A viruses from innate and adaptive immune responses. Viruses (2012) 1.06
FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity. Cytometry A (2008) 1.05
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha. Virus Res (2008) 1.05
Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis (2005) 1.04
Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection. PLoS One (2009) 1.02
Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002. J Infect Dis (2004) 1.01
Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS One (2010) 1.01
Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene. Vaccine (2006) 1.01
Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood (2012) 1.01
Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses. Emerg Infect Dis (2008) 1.00
Fecal-orally transmitted diseases among travelers are decreasing due to better hygienic standards at travel destination. J Travel Med (2010) 1.00
Travel-related dengue virus infection, The Netherlands, 2006-2007. Emerg Infect Dis (2011) 1.00
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog (2013) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
Occupational exposure to bloodborne viruses in the Amsterdam police force, 2000-2003. Am J Prev Med (2005) 1.00
Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, the Netherlands. J Hepatol (2013) 0.96
Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses. J Gen Virol (2012) 0.95
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. PLoS One (2009) 0.95
An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells. Virus Res (2007) 0.95
The incidence of HBV and HCV infection in Australian travelers. J Travel Med (2013) 0.95
Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine (2012) 0.94
Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets. J Gen Virol (2011) 0.93
Incidence, risk factors and treatment of diarrhoea among Dutch travellers: reasons not to routinely prescribe antibiotics. BMC Infect Dis (2011) 0.92
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution. J Gen Virol (2012) 0.92
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model. J Gen Virol (2010) 0.91